Why the study?
Does larger infarct size increase 5-year morbidity and mortality in patients with recent myocardial infarction?
Does larger infarct size increase 5-year morbidity and mortality in patients with recent myocardial infarction?
In patients with recent myocardial infarction, larger infarct size is a significant predictor of 5-year mortality but does not correlate with long-term morbidity.
Larger infarct size was associated with higher 5-year post-MI mortality but not morbidity; leaves open whether size modification improves outcomes.
In 809 patients with a recent myocardial infarction, morbidity during 5-year follow-up was assessed. The overall 5-year mortality rate was 33% (39% in patients with larger infarcts and 26% in patients with smaller infarcts) as judged from maximum serum enzyme activity (p less than .001). In terms of morbidity, no significant association with estimated infarct size was observed. Patients with smaller infarcts tended to have a higher reinfarction rate and were rehospitalized more often, whereas a similar proportion of patients with large and small infarcts developed stroke. Among survivors, chest pain tended to be more common in patients having smaller infarcts, whereas symptoms of dyspnea and claudicatio intermittens were similar in both groups, as were smoking habits, work capability, and varying forms of medication. We thus conclude that during a 5-year follow-up after acute myocardial infarction, mortality, but not morbidity, was related to the original infarct size.
No takes yet. Share an insight, caveat, or question.
Herlitz et al. (1988) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: